Foster & Motley’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.12M | Sell |
11,595
-936
| -7% | -$96K | 0.06% | 221 |
|
|
2025
Q4 | $1.33M | Sell |
12,531
-868
| -6% | -$101K | 0.07% | 204 |
|
|
2025
Q3 | $1.7M | Sell |
13,399
-1,115
| -8% | -$133K | 0.09% | 185 |
|
|
2025
Q2 | $1.78M | Sell |
14,514
-1,125
| -7% | -$128K | 0.1% | 177 |
|
|
2025
Q1 | $1.58M | Sell |
15,639
-1,134
| -7% | -$111K | 0.1% | 178 |
|
|
2024
Q4 | $1.55M | Sell |
16,773
-177
| -1% | -$17.4K | 0.1% | 180 |
|
|
2024
Q3 | $1.64M | Sell |
16,950
-971
| -5% | -$87.3K | 0.1% | 171 |
|
|
2024
Q2 | $1.54M | Sell |
17,921
-1,806
| -9% | -$152K | 0.11% | 170 |
|
|
2024
Q1 | $1.63M | Sell |
19,727
-2,369
| -11% | -$173K | 0.11% | 168 |
|
|
2023
Q4 | $1.47M | Sell |
22,096
-1,168
| -5% | -$75.7K | 0.11% | 169 |
|
|
2023
Q3 | $1.56M | Buy |
23,264
+1,640
| +8% | +$113K | 0.13% | 161 |
|
|
2023
Q2 | $1.46M | Sell |
21,624
-1,442
| -6% | -$90.4K | 0.11% | 179 |
|
|
2023
Q1 | $1.25M | Sell |
23,066
-90
| -0.4% | -$5.24K | 0.1% | 191 |
|
|
2022
Q4 | $1.39M | Sell |
23,156
-1,182
| -5% | -$64.3K | 0.12% | 182 |
|
|
2022
Q3 | $1.1M | Sell |
24,338
-9,914
| -29% | -$496K | 0.1% | 188 |
|
|
2022
Q2 | $1.53M | Sell |
34,252
-2,387
| -7% | -$122K | 0.13% | 152 |
|
|
2022
Q1 | $2.07M | Sell |
36,639
-4,144
| -10% | -$216K | 0.16% | 135 |
|
|
2021
Q4 | $2.12M | Sell |
40,783
-3,083
| -7% | -$159K | 0.16% | 136 |
|
|
2021
Q3 | $2.62M | Sell |
43,866
-419
| -0.9% | -$26.4K | 0.22% | 116 |
|
|
2021
Q2 | $2.75M | Sell |
44,285
-1,509
| -3% | -$101K | 0.23% | 115 |
|
|
2021
Q1 | $2.98M | Sell |
45,794
-628
| -1% | -$41K | 0.25% | 102 |
|
|
2020
Q4 | $3.05M | Sell |
46,422
-1,368
| -3% | -$80.5K | 0.3% | 87 |
|
|
2020
Q3 | $2.47M | Sell |
47,790
-1,384
| -3% | -$71K | 0.29% | 96 |
|
|
2020
Q2 | $2.42M | Sell |
49,174
-1,547
| -3% | -$83.5K | 0.3% | 95 |
|
|
2020
Q1 | $2.58M | Buy |
50,721
+2,618
| +5% | +$151K | 0.39% | 78 |
|
|
2019
Q4 | $2.65M | Buy |
48,103
+164
| +0.3% | +$8.9K | 0.33% | 86 |
|
|
2019
Q3 | $2.41M | Buy |
47,939
+4,593
| +11% | +$231K | 0.33% | 89 |
|
|
2019
Q2 | $2.19M | Buy |
43,346
+6,596
| +18% | +$320K | 0.31% | 95 |
|
|
2019
Q1 | $1.71M | Buy |
36,750
+9,220
| +33% | +$467K | 0.25% | 101 |
|
|
2018
Q4 | $1.35M | Buy |
27,530
+5,069
| +23% | +$288K | 0.22% | 110 |
|
|
2018
Q3 | $1.39M | Buy |
22,461
+1,802
| +9% | +$110K | 0.21% | 102 |
|
|
2018
Q2 | $1.11M | Buy |
20,659
+3,643
| +21% | +$182K | 0.18% | 115 |
|
|
2018
Q1 | $774K | Buy |
17,016
+5,767
| +51% | +$247K | 0.13% | 139 |
|
|
2017
Q4 | $442K | Buy |
11,249
+5,478
| +95% | +$208K | 0.07% | 166 |
|
|
2017
Q3 | $213K | Buy |
+5,771
| New | +$206K | 0.04% | 199 |
|
Other funds holding EHC
VPM
VCM
Foster & Motley's EHC Position: Q1 2026 in Review
Foster & Motley reduced its Encompass Health (EHC) stake by 7.5% in Q1 2026, selling an estimated $96K and leaving 11,595 shares worth $1.12M. The position accounts for 0.06% of the portfolio, ranked #221.
Foster & Motley first reported a position in EHC in Q3 2017 and has held it in 35 quarters since. The position peaked at $3.05M in Q4 2020. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Foster & Motley held 11,595 shares of Encompass Health worth $1.12M as of Q1 2026.
- Foster & Motley sold 936 Encompass Health shares in Q1 2026, an estimated $96K.
- Encompass Health made up 0.06% of Foster & Motley's portfolio in Q1 2026, its #221 holding.
- Foster & Motley first reported a position in Encompass Health in Q3 2017 and has held it in 35 quarters since.
- Foster & Motley's Encompass Health position peaked at $3.05M in Q4 2020.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.